Relation between mutations in the 5′ UTR of ANKRD26 gene and inherited thrombocytopenia with predisposition to myeloid malignancies. An Egyptian study

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity

(2020) Shannon Lee et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Diagnosis of Inherited Platelet Disorders on a Blood Smear

(2020) Carlo Zaninetti et al.   Journal of Clinical Medicine

Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia

(2019) Pallavi Galera et al.   International Journal of Laboratory Hematology

Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26 -related Thrombocytopenia and MYH9 -related diseases

(2018) Alessandra Balduini et al.   European Journal of Medical Genetics

5’UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

(2017) Caterina Marconi et al.   Journal of Hematology & Oncology

Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases

(2017) C. Zaninetti et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected

(2017) Silvia Ferrari et al.   PLATELETS

Clinical and laboratory characteristics in congenitalANKRD26mutation-associated thrombocytopenia: A detailed phenotypic study of a family

(2016) Juliana Perez Botero et al.   PLATELETS

Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults

(2015) Daria V. Babushok et al.   LEUKEMIA & LYMPHOMA

Trametinib: a MEK inhibitor for management of metastatic melanoma

(2015) Piotr Rutkowski et al.   OncoTargets and Therapy

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26

(2015) J Perez Botero et al.   Blood Cancer Journal

Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation

(2014) Dominique Bluteau et al.   JOURNAL OF CLINICAL INVESTIGATION

A new family with a germlineANKRD26mutation and predisposition to myeloid malignancies

(2014) Rafael Marquez et al.   LEUKEMIA & LYMPHOMA

ITP and international guidelines: What do we know, what do we need?

(2014) Francesco Rodeghiero et al.   PRESSE MEDICALE

ANKRD26-related thrombocytopenia and myeloid malignancies

(2013) P. Noris et al.   BLOOD

Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombocytopenia

(2012) Vittorio Necchi et al.   THROMBOSIS AND HAEMOSTASIS

Mutations in the 5′ UTR of ANKRD26, the Ankirin Repeat Domain 26 Gene, Cause an Autosomal-Dominant Form of Inherited Thrombocytopenia, THC2

(2011) Tommaso Pippucci et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families

(2011) P. Noris et al.   BLOOD

Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice

(2011) G. A. Raciti et al.   DIABETOLOGIA

Ankrd26Gene Disruption Enhances Adipogenesis of Mouse Embryonic Fibroblasts

(2011) Zhaoliang Fei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)

(2008) A. Pecci et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION